Mexico clears for use the world's first dengue fever vaccine


Now that the world's first dengue vaccine has won regulatory approval in Mexico, health officials there estimate it will prevent 8,000 hospitalizations and 104 deaths a year.
As many as 400 million people around the globe are infected with dengue every year, the World Health Organization says, and it is endemic in more than 100 countries. It's the fastest-growing mosquito-borne disease in the world and has no known cure, and kids are particularly at risk of becoming infected. There are four separate strains of dengue, and the deadliest form kills 22,000 people every year.
Researchers had to come up with a vaccine that could immunize people against each strain, and clinical tests of 40,000 participants from 15 countries found that the vaccine can immunize two-thirds of people 9 years old and up. The vaccine, Dengvaxia, is manufactured by the French company Sanofi, which has requested regulatory approval in 20 countries across Latin America and Asia. The price hasn't been decided yet, but the head of Sanofi's vaccines division says it could generate more than $1 billion a year in revenue, Agence France-Presse reports. Mexico's National Vaccination Council will soon convene to determine if the country will start giving residents Dengvaxia for free, said Mikel Arriola, the head of the regulatory agency. "It's a great step forward," he told AFP.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County